Beechbrook Capital supports DACH-based Dermedis with acquisition finance
30 August 2019
2 September 2019 – Beechbrook has recently closed its 13th investment in its Private Debt III fund with an investment in Dermedis alongside Rigeto Unternehmerkapital (“Rigeto”) and the management team. Beechbrook provided debt and equity in the transaction to support an add-on acquisition.
Dermedis is a provider of non-surgical beauty treatments with locations in Germany and Switzerland. It also has an online presence offering a wide range of products and services.
Beechbrook’s investment was used to support the add-on acquisition of Clinique Matignon, a leading aesthetic clinic network in Switzerland focusing on a wide range of ambulatory aesthetic medical treatments. The acquisition creates one of the largest chains of high-end beauty treatment centres in the DACH (Germany, Austria and Switzerland) region.
Dermedis was acquired by Rigeto in 2018 with the goal to create a leading group of clinics in the DACH region organically, as well as via strategic acquisitions. Rigeto has substantial experience in the industry and in executing complex buy-and-build, as well as roll-out, strategies.
Richard Lenz, managing partner at Rigeto, said:
“It was a pleasure working with Beechbrook on the add-on acquisition of Clinique Matignon. Their flexibility and pragmatic approach to providing a tailored financing solution was of great value to us and helped to get the transaction over the line.”
Sandeep Agarwal, partner at Beechbrook, commented:
“We are delighted to have closed this acquisition with Rigeto in pursuit of their growth strategy for Dermedis. We are looking forward to seeing Rigeto and the management team taking the group to the next level.”